Synthesis of New ۲-Azetidinone Derivatives and Related Schiff Bases from ۳-Phenyl-۲,۳,۶,۷-tetrahydroimidazo [۲,۱-b] Thiazolo [۵,۴-d] Isoxazole

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 91

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ORGC-5-1_005

تاریخ نمایه سازی: 3 مهر 1402

چکیده مقاله:

۲-Azetidinones, commonly known as β-lactams, are well-known heterocyclic compounds. Herein we described the synthesis of a series of novel β-lactams. The efficient and rapid synthesis of novel β-lactams has been established in good yields starting from (R)-۳-phenyl-۲, ۳, ۶, ۷-tetrahydroimidazo [۲', ۱':۲, ۳] thiazolo [۵, ۴-d] isoxazole ۱. First, (R)-۳-phenyl-۲, ۳, ۶, ۷-tetrahydroimidazo [۲', ۱':۲, ۳] thiazolo [۵, ۴-d] isoxazole ۱ on condensation with ethylchloro acetate yielded Ethyl (R) ۲-(۳-phenyl- ۶, ۷-dihydroimidazo [۲', ۱':۲,۳] thiazolo [۵, ۴-d] isoxazole-۲(۳H)-yl) acetate ۲, which on amination with hydrazine hydrate yielded (R) ۲-(۳-phenyl- ۶, ۷-dihydroimidazo [۲', ۱':۲, ۳] thiazolo [۵, ۴-d] isoxazol -۲(۳H)-yl) acetohydrazide ۳. Then, condensation between compound ۳ and various aromatic aldehydes give Schiff base derivatives ۴a-j, which upon dehydrative annulation in the presence of chloroacetyl chloride and triethylamine yielded N-((۳S, ۴S)-۳-chloro-۲-oxo-۴-phenylazetidin-۱-yl)-۲-((R)-۳-(Aryl)-۶, ۷-dihydroimidazo [۲', ۱':۲, ۳] thiazolo [۵, ۴-d] isoxazol -۲(۳H)-yl) acetamide ۵a-j. All synthesized compounds were characterized by elemental analyses, IR, ۱H-NMR and ۱۳C-NMR data.

نویسندگان

Hamid Reza Jaberi

Department of Production, Aburaihan Pharmaceutical Co., Tehran, Iran; R&D Division, Aburaihan Pharmaceutical Co., Tehran, Iran

Hanif Fattahi

Department of Production, Aburaihan Pharmaceutical Co., Tehran, Iran; R&D Division, Aburaihan Pharmaceutical Co., Tehran, Iran

Arman Ahmannasrollahi

Department of Production, Aburaihan Pharmaceutical Co., Tehran, Iran

Mohammadreza Yarandpour

Department of Production, Aburaihan Pharmaceutical Co., Tehran, Iran

Sharareh Sedaghatizadeh

Department of Production, Aburaihan Pharmaceutical Co., Tehran, Iran